By Scott Hensley, NPR
Concerns about drug risks have led 28 state attorneys general to ask the Food and Drug Administration to reverse its approval of Zohydro, a long-acting narcotic painkiller, before the medicine is even put on the market.
The risks for addiction and overdose from the potent opioid outweigh the benefits of pain relief, critics say. Some point to the risk for children, in particular. A single capsule of Zohydro could kill a kid, the medicine’s instructions warn.
Other opioid painkillers, such as Vicodin and Percocet, are already fixtures in America’s medicine cabinets. And as the prescriptions for drugs like these have surged, so have the reports of overdoses and deaths — for children and adults.